A Fatal Adverse Effect of Barbiturate Coma Therapy: Dyskalemia / 대한신경손상학회지
Korean Journal of Neurotrauma
;
: 156-158, 2016.
Article
Dans Anglais
| WPRIM
| ID: wpr-122136
ABSTRACT
The management guideline for traumatic brain injury (TBI) recommends high-dose barbiturate therapy to control increased intracranial pressure refractory to other therapeutic options. High-dose barbiturate therapy, however, may cause many severe side effects; the commonly recognized ones include hypotension, immunosuppression, hepatic dysfunction, renal dysfunction, and prolonged decrease of cortical activity. Meanwhile, dyskalemia remains relatively uncommon. In this study, we report the case of a hypokalemic patient with severe rebound hyperkalemia, which occurred as a result of barbiturate coma therapy administered for TBI treatment.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Lésions encéphaliques
/
Pression intracrânienne
/
Immunosuppression thérapeutique
/
Coma
/
Hyperkaliémie
/
Hypokaliémie
/
Hypotension artérielle
Type d'étude:
Guide de pratique
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Korean Journal of Neurotrauma
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS